Mountain Valley MD Holdings appoints Gokul Kannan and Mark Gelnaw as new advisors and updates on listing plans

Mountain Valley MD Holdings Inc (CSE:MVMD) (OTCMKTS:MVMD) revealed it had appointed two new advisors and updated on its uplisting plan, saying it was considering the Toronto-based NEO exchange.

Gokul Kannan and Mark Gelnaw are the new advisory appointments, it revealed, as the company is advancing its oncology work and broadening the commercial applications of its desiccated liposome and solubilization technology.

READ: Mountain Valley MD Holdings says its Quicksome technology could change vaccine landscape after cold chain tests

Kannan is an inventor and partner at Zephyr Venture Partners and a rising star in bioengineering and chemical engineering research.

He has four pending patents including both therapeutic and device patents and his work has been featured in The New York Times, Science Magazine, The Economist, and more than 15 other major science news outlets.

Meanwhile, Gelnaw is an esteemed financial executive whose career spans more than 35 years in financial management, business leadership, and corporate strategy, noted Mountain Valley.

His past executive roles include as chief operating officer (COO) of Deutsche Bank, chief operating and financial officer at Lehman Brothers, along with senior roles at Salomon Brothers and Arthur Andersen.

“I am extremely proud to welcome Gokul and Mark to our Advisory Board at Mountain Valley MD and look forward to their immediate contributions at this critical growth phase of our company,” said Dennis Hancock, the CEO of Mountain Valley MD.

“The collective knowledge and deep experience brought to our team from our new advisors will be invaluable as we advance our key oncology and technology projects, as well as contributing to our overall business maturation in the biotech space.”

Also in the statement, the firm said it had proceeded with an application to list its shares on the  TSX Venture Exchange (TSXV) but was also considering the value proposition of listing on the NEO exchange

“The NEO Exchange is a recognized Canadian exchange for senior public companies and investment products. Operating since mid-2015, NEO was launched with the stated purpose of providing Canadians with a stock exchange that puts the interest of capital-raising companies, investors and their dealers first. The company is reviewing options with its Board of Directors and anticipates making a broader uplisting decision by early August 2021,” it said.

Contact the writer at [email protected]

Story by ProactiveInvestors